Results for tag: "Canagliflozin Metformin"

Canagliflozin Metformin is a combination drug used to treat type 2 diabetes. It is a combination of two drugs, canagliflozin and metformin, which work together to reduce blood sugar levels. Canagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the body remove excess glucose from the blood. Metformin is a biguanide, which helps the body respond better to insulin. Together, these two drugs can help reduce the risk of long-term complications associated with diabetes, such as heart disease, stroke, and kidney disease. Canagliflozin Metformin is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and obesity. These drugs are used to help manage symptoms and reduce the risk of long-term complications. Some companies in the Canagliflozin Metformin market include Johnson & Johnson, Merck & Co., Sanofi, and Novo Nordisk. Show Less Read more